G6PC1 and type 2 diabetes mellitus: Lin et al. [36] found that astragaloside IV can reduce the levels of blood glucose, triglyceride, and insulin in type 2 diabetic mice and inhibit the mRNA and protein expression and enzyme activity of liver glycogen phosphorylase (GP) and glucose 6-phosphatase (G6Pase).